HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dag Nyholm Selected Research

Dopamine Agonists (Dopamine Agonist)

1/2006Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dag Nyholm Research Topics

Disease

49Parkinson Disease (Parkinson's Disease)
10/2023 - 03/2002
9Dyskinesias (Dyskinesia)
01/2021 - 10/2006
4Parkinsonian Disorders (Parkinsonism)
12/2023 - 01/2017
3Infections
01/2021 - 04/2009
2Normal Pressure Hydrocephalus
10/2023 - 02/2022
2Huntington Disease (Huntington's Disease)
01/2021 - 11/2019
2Torticollis (Wryneck)
09/2015 - 11/2012
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2023
1Multiple System Atrophy
01/2023
1Synucleinopathies
01/2023
1Neutropenia
12/2022
1Agranulocytosis (Granulocytopenia)
12/2022
1Disease Progression
12/2022
1Body Weight (Weight, Body)
12/2022
1Helicobacter Infections
01/2021
1Psychotic Disorders (Schizoaffective Disorder)
01/2018
1Movement Disorders (Movement Disorder)
10/2017
1Inflammation (Inflammations)
04/2009

Drug/Important Bio-Agent (IBA)

40Levodopa (L Dopa)FDA LinkGeneric
12/2022 - 03/2002
25Carbidopa (Lodosyn)FDA LinkGeneric
06/2022 - 10/2006
4Dopamine (Intropin)FDA LinkGeneric
10/2017 - 01/2006
3N- (3- iodoprop- 2- enyl)- 2- beta- carbomethoxy- 3- (4- methylphenyl)nortropaneIBA
12/2023 - 01/2017
3levodopa drug combination carbidopa (Nakom)FDA LinkGeneric
01/2016 - 05/2003
2Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
12/2023 - 01/2017
2Biomarkers (Surrogate Marker)IBA
01/2023 - 02/2022
2entacapone (Comtan)FDA Link
01/2022 - 01/2017
2SuspensionsIBA
03/2017 - 03/2008
2Botulinum Toxins (Botulinum Toxin)IBA
09/2015 - 11/2012
2Type A Botulinum Toxins (Botox)FDA Link
09/2015 - 11/2012
2abobotulinumtoxinAFDA Link
09/2015 - 11/2012
1LigandsIBA
12/2023
1CytokinesIBA
10/2023
1Proteins (Proteins, Gene)FDA Link
10/2023
1SynucleinsIBA
01/2023
1IronIBA
12/2022
1DeferiproneIBA
12/2022
1Chelating AgentsIBA
12/2022
1SolutionsIBA
06/2022
1ApomorphineFDA Link
01/2021
1proenkephalinIBA
01/2021
1Phenylalanine (L-Phenylalanine)FDA Link
11/2019
1Tyrosine (L-Tyrosine)FDA Link
11/2019
1N- (3- fluorophenyl)- 1- ((4- (((3S)- 3- methyl- 1- piperazinyl)methyl)phenyl)acetyl)- 4- piperidinamineIBA
01/2018
1mesdopetamIBA
01/2018
1Folic Acid (Vitamin M)FDA LinkGeneric
12/2013
1HomocysteineIBA
12/2013
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
12/2013
13-methoxytyrosineIBA
04/2013
1StalevoIBA
02/2011
1TitaniumIBA
04/2009
1Dopamine Receptors (Dopamine Receptor)IBA
10/2006
1Dopamine Agonists (Dopamine Agonist)IBA
01/2006
1Dopamine Agents (Dopaminergic Agents)IBA
01/2006
1Carboxy-LyasesIBA
09/2004
1Drug CombinationsIBA
03/2002

Therapy/Procedure

10Therapeutics
10/2023 - 09/2004
3Drug Therapy (Chemotherapy)
01/2021 - 01/2006
2Oral Administration
07/2021 - 03/2019
2Deep Brain Stimulation
01/2021 - 11/2013
2Activities of Daily Living (ADL)
09/2015 - 03/2002
1Transplantation
10/2023
1Intravenous Infusions
06/2022
1Precision Medicine
07/2021
1Drug Tapering
01/2017
1Aftercare (After-Treatment)
09/2015
1Intramuscular Injections
09/2015
1Gastrostomy
04/2009
1Polypharmacy
01/2009